Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F9DTJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,299
Award facts
- Contract value 100% obligated
- $10,299.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,299.18 delivery order (Contract 4570600134) to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors on January 22, 2026, with completion scheduled for January 23, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's Conshohocken, Pennsylvania location. The contract represents a task order against AmerisourceBergen's parent company Cencora, Inc.'s larger indefinite delivery contract with DLA Troop Support Medical, a $999,999,999 vehicle running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor, regularly fulfills DLA medical procurement needs across a diverse range of therapeutic domains. Enbrel is a specialty biologic medication used primarily for autoimmune conditions such as rheumatoid arthritis and certain inflammatory disorders, reflecting the types of essential pharmaceutical products the contractor supplies to support military treatment facilities and veteran healthcare programs. This delivery order exemplifies the company's role as a key supplier in the federal pharmaceutical supply chain, enabling the delivery of both brand-name specialty medications and comprehensive medical commodities to support ongoing military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F9DTJ?
SPE2DR26F9DTJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F9DTJ worth?
The government has obligated $10,299 on SPE2DR26F9DTJ.
Is contract SPE2DR26F9DTJ an order under another contract?
Yes. SPE2DR26F9DTJ is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9DTJ competed?
The extent of competition for SPE2DR26F9DTJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award